Form 8-K - Current report:
SEC Accession No. 0001493152-25-006584
Filing Date
2025-02-14
Accepted
2025-02-14 07:55:50
Documents
18
Period of Report
2025-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48813
2 ex5-1.htm EX-5.1 11820
3 ex10-1.htm EX-10.1 259146
4 ex10-2.htm EX-10.2 148359
5 ex10-3.htm EX-10.3 162731
6 ex5-1_001.jpg GRAPHIC 3196
  Complete submission text file 0001493152-25-006584.txt   930816

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vvos-20250214.xsd EX-101.SCH 3006
8 XBRL LABEL FILE vvos-20250214_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE vvos-20250214_pre.xml EX-101.PRE 24159
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 25623274
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)